Gastroenterology Unit, Department of Medicine, University of Nigeria Teaching Hospital, Ituku-Ozalla, Enugu, Nigeria.
Department of Medicine, Faculty of Medical Sciences, College of Medicine, University of Nigeria, Ituku-Ozalla Campus, Enugu, Nigeria.
Niger J Clin Pract. 2024 Mar 1;27(3):352-360. doi: 10.4103/njcp.njcp_365_23. Epub 2024 Mar 26.
Nonalcoholic fatty liver disease (NAFLD) is now adjudged the most common liver disease in the world, contributing to the rising incidence of hepatocellular carcinoma worldwide. However, the true prevalence of nonalcoholic fatty liver disease among obese individuals and its contribution to the burden of liver disease in Nigeria is unknown.
To determine the prevalence of nonalcoholic fatty liver disease and associated risk factors in obese subjects.
This was a cross-sectional analytical study of 280 obese subjects and 280 nonobese age and sex-matched controls seen at our health facility. Data collection was done using an interviewer-administered questionnaire and anthropometric parameters were obtained. Fasting blood samples were collected for blood glucose, lipid profile, and liver biochemistry. Abdominal ultrasound was used to screen for NAFLD. The results were subjected to relevant statistical analysis using SPSS version 20.
A higher prevalence of NAFLD was found in obese subjects, compared with nonobese controls (36.4% versus 0.4% P < 0.001). The degree of obesity, transaminases, total cholesterol, diastolic hypertension, fasting blood glucose, and waist circumference was significantly associated with a higher prevalence of NAFLD. However, using multivariate logistic regression analysis, diabetes mellitus and hypertension were significant associations for NAFLD. Individuals with NAFLD had a significantly higher prevalence of metabolic syndrome 65.9%, compared with 34.1% in obese individuals without NAFLD (P < 0.001).
The prevalence of NAFLD in obese subjects was significant. NAFLD in obese subjects was associated with degree of obesity, hyperlipidemia, hypertension, and diabetes mellitus.
非酒精性脂肪性肝病(NAFLD)现已被判定为全球最常见的肝脏疾病,导致全球肝细胞癌发病率上升。然而,肥胖人群中非酒精性脂肪性肝病的真实患病率及其在尼日利亚肝脏疾病负担中的作用尚不清楚。
确定肥胖人群中非酒精性脂肪性肝病的患病率及其相关危险因素。
这是一项在我们医疗机构就诊的 280 名肥胖受试者和 280 名非肥胖年龄和性别匹配对照者中进行的横断面分析性研究。使用访谈者管理的问卷进行数据收集,并获得人体测量参数。采集空腹血样进行血糖、血脂和肝功能检查。使用腹部超声筛查非酒精性脂肪性肝病。使用 SPSS 版本 20 对结果进行相关统计分析。
与非肥胖对照组相比,肥胖受试者中非酒精性脂肪性肝病的患病率更高(36.4%对 0.4%,P<0.001)。肥胖程度、转氨酶、总胆固醇、舒张期高血压、空腹血糖和腰围与非酒精性脂肪性肝病的高患病率显著相关。然而,使用多变量逻辑回归分析,糖尿病和高血压是非酒精性脂肪性肝病的显著关联因素。患有非酒精性脂肪性肝病的个体的代谢综合征患病率明显更高,为 65.9%,而无非酒精性脂肪性肝病的肥胖个体的患病率为 34.1%(P<0.001)。
肥胖人群中非酒精性脂肪性肝病的患病率显著。肥胖人群中,非酒精性脂肪性肝病与肥胖程度、血脂异常、高血压和糖尿病有关。